Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation.
about
C/EBPβ regulates sensitivity to bortezomib in prostate cancer cells by inducing REDD1 and autophagosome-lysosome fusionSclareol inhibits cell proliferation and sensitizes cells to the antiproliferative effect of bortezomib via upregulating the tumor suppressor caveolin-1 in cervical cancer cells.Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibitionCeramide metabolism regulates autophagy and apoptotic cell death induced by melatonin in liver cancer cells.The Proteasome Inhibitor Bortezomib Affects Chondrosarcoma Cells via the Mitochondria-Caspase Dependent Pathway and Enhances Death Receptor Expression and AutophagyAnti-tumoral effect of desmethylclomipramine in lung cancer stem cells.Microtargeting cancer metabolism: opening new therapeutic windows based on lipid metabolismp73 regulates basal and starvation-induced liver metabolism in vivo.Effect of the specific proteasome inhibitor bortezomib on cancer-related muscle wasting.Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms.Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma.IL-1β-Induced Accumulation of Amyloid: Macroautophagy in Skeletal Muscle Depends on ERK.The fucosylated CD147 enhances the autophagy in epithelial ovarian cancer cells.Autophagy as an emerging therapy target for ovarian carcinomaBortezomib-Induced Muscle Toxicity in Multiple Myeloma.The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome Inhibitors.The role of autophagy in the cytotoxicity induced by recombinant human arginase in laryngeal squamous cell carcinoma.Platinum pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via DUB inhibition-dependent caspase activation and Bcr-Abl downregulation.MG132-induced progerin clearance is mediated by autophagy activation and splicing regulation.Cisplatin, Oxaliplatin, and Kiteplatin Subcellular Effects Compared in a Plant Model.Lysine-specific demethylase 1 (LSD1) destabilizes p62 and inhibits autophagy in gynecologic malignancies.Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer.BaxΔ2 sensitizes colorectal cancer cells to proteasome inhibitor-induced cell death.HSV‑TK/GCV can induce cytotoxicity of retinoblastoma cells through autophagy inhibition by activating MAPK/ERK.
P2860
Q28391156-15BD6673-2521-4A18-8835-D28ADD268A64Q33702153-62531C9A-4341-4AF2-B55F-34F736C35D62Q33801982-A8847703-9A7D-4470-87F9-A4C27F0C4EF1Q35912091-40E91221-B4AE-47C4-9A61-8C5D42D009EAQ36225532-85C444AF-990F-4030-9F72-8AA55812CD4CQ36231919-74C3C599-8570-4F51-8EBC-7BA5DE05F31FQ36503853-79FC72D8-5897-4B1A-94EB-F7F6E67DDC24Q36545105-5D23F66A-A0CF-4F4D-A13C-94682A3ECA20Q36893329-7E47DEEC-E826-4384-9113-39E7755F4E9CQ37440054-C51E8D8B-BC7D-4FDE-BD5B-A828B8D99752Q37520396-689BA343-F8A8-4967-90C9-9726742307D4Q37607376-264A1793-A1AE-4F73-BD41-0E9C0E7A9766Q37696238-E10C0588-EABF-42B7-860B-F5BB51B9BC02Q37696331-2DC30DC6-B238-45E7-896A-436D4DB5C3E6Q38597695-89D087D2-6C94-4B7C-933A-00747927A215Q38820789-75D5C113-F47E-4C93-9207-34D7E66BDB85Q38883330-4AF69792-27C5-4A50-B56D-38D87BC94361Q41335233-80461073-B6F9-4D8A-8DA3-7BEB8FB4E3E6Q41601030-F2896008-C51E-4EAA-9ECF-162A9AE8A923Q42317364-D75D3906-81F9-4F4E-87BE-F2401931EDFBQ43044672-5AE623D6-EBEF-4DCC-A822-ECFA6F3DF3CCQ47140422-7E0F6229-C607-4B41-8245-F9EB58265DC0Q47240693-A9ABD98F-C8E8-4954-B873-51A6F9E48F08Q54977772-894C4857-AECB-4657-9080-1957F4B84683
P2860
Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Bortezomib enhances cancer cel ...... imulating ERK phosphorylation.
@ast
Bortezomib enhances cancer cel ...... imulating ERK phosphorylation.
@en
Bortezomib enhances cancer cel ...... imulating ERK phosphorylation.
@nl
type
label
Bortezomib enhances cancer cel ...... imulating ERK phosphorylation.
@ast
Bortezomib enhances cancer cel ...... imulating ERK phosphorylation.
@en
Bortezomib enhances cancer cel ...... imulating ERK phosphorylation.
@nl
prefLabel
Bortezomib enhances cancer cel ...... imulating ERK phosphorylation.
@ast
Bortezomib enhances cancer cel ...... imulating ERK phosphorylation.
@en
Bortezomib enhances cancer cel ...... imulating ERK phosphorylation.
@nl
P2093
P2860
P356
P1476
Bortezomib enhances cancer cel ...... timulating ERK phosphorylation
@en
P2093
W-C Chuang
P2860
P356
10.1038/CDDIS.2014.468
P577
2014-11-06T00:00:00Z